Unfortunately their arrogance will stand in the way yet again. Management made it clear that fiscally responsible controls would not occur. The delay in AZN trials are very concerning as well. SK should also be buying stock on open market and show some leadership skills. Instead of hiding!
Paul, I agree with you completely. Management needs to lay out a plan. Stopping trials to reduce expenses is not what I would consider fiscal responsibility. Evaluating where Sunrise went wrong while salaries continue to be dolled out is not a plan. Whereas, I understand there needs to be an assessment of the data, I don't believe much will come of it. As some have said, we will most likely see no data from sunrise.